History in the USA
Founded in 1999, Ceva has become one of the fastest growing animal health companies in the world. Since 2000, Ceva has completed more than 30 successful business integrations accounting for 40 percent of overall growth.
Here is a brief history of Ceva's expansion in the United States.
2024
Acquired Scout Bio. Inc.
Announced the acquisition of Scout Bio, pioneer in biotechnology.
2023
Opening of dedicated genomics center
Opening of Ceva’s Genomic Innovations Center in Shawnee, Kansas
2021
CARDALIS® now available in the U.S.
Launch of CARDALIS® (spironolactone and benazepril) the first product in Ceva's U.S. cardiology portfolio.
2021
Launched FELIWAY® OPTIMUM - a new pheromone discovery
FELIWAY® Optimum's patented formula mimics natural cat pheromones to help cats with more signs of stress
2020
Ceva's U.S. C.H.I.C.K. Program receives independently audited quality recognition from Bureau Veritas
The team, part of Ceva’s global hatchery vaccination services program for poultry, known commonly as the C.H.I.C.K Program, received quality recognition from the international testing and certification company, Bureau Veritas Group.
2020
Acquired Vaccine Facility in Verona, Wisconsin
Ceva expands its production footprint in the U.S. with new facility to focus entirely on custom vaccine production for poultry and swine.
2019
Acquired THUNDERWORKS® expanding Ceva's behavior range of products
Acquired THUNDERWORKS® expanding Ceva's behavior range of products
2015
Ceva receives US patent for innovative delivery system for treating poultry hatchlings
A soft edible gel serves as a carrier for vaccines, probiotics and nutritional supplements to poultry in the hatchery
2015
Completed 10,000 sq. ft. expansion of vaccine production facilities
Ceva expanded facilities to meet demand for its vaccine products.
2013
Opened state-of-the-art research and development facility in Lenexa
Ceva completed a $7 million expansion of its research and development (R&D) facility on the Lenexa, Kan. campus.
2013
Acquired Sogeval Laboratories
Ceva Animal Health has acquired Sogeval, a subsidiary of Sofiprotéol, solidifying Ceva’s position as a Top 10 global animal health company.
2011
New multi-million-dollar poultry vaccine facility opens on the Lenexa campus
Ceva completes a significant investment, consolidating activities in Lenexa, Kansas and preparing for growth to provide poultry vaccines for the global industry
2010
Acquired Summit VetPharm adding the Vectra brand of parasiticides to its companion animal portfolio
Ceva entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquire a majority share of Sumitomo’s animal health subsidiary Summit VetPharm.
2005
Acquired Biomune Company, a high-tech vaccine manufacturer in Lenexa, Kansas.
This acquisition allowed Ceva to enhance its portfolio with a range of USDA licensed and customized vaccines for poultry.
2002
Established U.S. business with launch of FELIWAY® and ADAPTIL® pheromone diffusers
Leaning on the prestige of its behavior product category, Ceva enters the U.S. market.
Ceva Wildlife Research Fund
Ceva Wildlife Research Fund, empowering science to protect vulnerable animals.